Experienced in Hemolytic Anemia

Nicole A. Blijlevens

Nijmegen, GE, NL 
Experienced in Hemolytic Anemia
Nijmegen, GE, NL 
OverviewLocationsClinical Research

Overview

Nicole Blijlevens practices in Nijmegen, Netherlands. Ms. Blijlevens is rated as an Experienced expert by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Agranulocytosis, Chronic Myelogenous Leukemia (CML), Febrile Neutropenia, Bone Marrow Transplant, and Splenectomy.

Her clinical research consists of co-authoring 228 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles in the study of Hemolytic Anemia.

Gender
Female

Locations

Nijmegen, GE, Netherlands
Other Locations
Netherlands
Amsterdam, NH, Netherlands
University Medical Centre St. Radboud Nijmegen, PO Box 9101, Wageningen, GE 6500HB, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Safety and Efficacy of Interleukin-1 Inhibitor Anakinra for the Amelioration of Fever During Neutropenia and Mucositis in Patients With Multiple Myeloma Receiving an Autologous Stem Cell Transplantation After High-dose Melphalan
Safety and Efficacy of Interleukin-1 Inhibitor Anakinra for the Amelioration of Fever During Neutropenia and Mucositis in Patients With Multiple Myeloma Receiving an Autologous Stem Cell Transplantation After High-dose Melphalan
Enrollment Status: Completed
Publish Date: November 18, 2024
Intervention Type: Drug
Study Phase: Phase 2
Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections
Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections
Enrollment Status: Completed
Publish Date: December 16, 2019
Intervention Type: Drug
Study Phase: Phase 4
A Phase I/II Multicentric Study to Determine the Safety and Efficacy of a Combination of Anti-CD3 & Anti-CD7 Ricin A Immunotoxins (T-Guard) for the Treatment of Steroid-resistant Acute Graft-versus-Host Disease.
A Phase I/II Multicentric Study to Determine the Safety and Efficacy of a Combination of Anti-CD3 & Anti-CD7 Ricin A Immunotoxins (T-Guard) for the Treatment of Steroid-resistant Acute Graft-versus-Host Disease.
Enrollment Status: Completed
Publish Date: June 06, 2017
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

228 Total Publications

Challenges in predicting outcomes for watch and wait follicular lymphoma patients: insights into clinical, pathological, and molecular factors.
Challenges in predicting outcomes for watch and wait follicular lymphoma patients: insights into clinical, pathological, and molecular factors.
Journal: Leukemia & lymphoma
Published: October 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Blijlevens's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile